Securin promotes the identification of favourable outcome in invasive breast cancer. - Test2 - elhamkhani - TriplyDB

Securin promotes the identification of favourable outcome in invasive breast cancer.

Securin promotes the identification of favourable outcome in invasive breast cancer.

http://www.wikidata.org/entity/Q37345354

about

Cdc20 and securin overexpression predict short-term breast cancer survival.Pituitary tumor-transforming gene and its binding factor in endocrine cancer.Low cdc27 and high securin expression predict short survival for breast cancer patients.

P2860

Q33750165-16E3405F-7F29-42B5-AA7A-6D5C8041E699 Q37815569-8B9C6D16-E534-4FF2-9D5E-330C89EBB835 Q50918197-C4734259-C410-45FC-BF6D-17EA66FFB1B4

P2860

Securin promotes the identification of favourable outcome in invasive breast cancer.

http://www.wikidata.org/entity/Q37345354

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 August 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Securin promotes the identification of favourable outcome in invasive breast cancer.

@en

Securin promotes the identification of favourable outcome in invasive breast cancer.

@nl

type

label

Securin promotes the identification of favourable outcome in invasive breast cancer.

@en

Securin promotes the identification of favourable outcome in invasive breast cancer.

@nl

prefLabel

Securin promotes the identification of favourable outcome in invasive breast cancer.

@en

Securin promotes the identification of favourable outcome in invasive breast cancer.

@nl

P1433

Q37345354-085CE6EB-8462-4E38-897A-24C3957868E9

P1476

Q37345354-4078356F-8DD9-4A29-BE93-D2C30907097C

P2093

Q37345354-0F30D1ED-58F9-4F11-A74E-1E2644BC9DC1

Q37345354-10775E4C-1FB1-4528-9DDE-7182C8388E56

Q37345354-389B5544-3E34-4529-88F1-4434558A655F

Q37345354-4DF15678-4A45-4B0B-B280-6970247AA6AC

Q37345354-5B5B8D41-60C4-4B2D-BE8A-ABC407E33DFF

Q37345354-989056A7-59E2-4B29-A909-47186886B1E2

Q37345354-BDCE5C2D-2D46-4387-9370-26C9C0DB5F9B

Q37345354-DDA55C31-0D16-414F-89AE-D7BA59570017

P2860

Q37345354-0924CB8D-661F-4636-8030-990319AFDC5A

Q37345354-0B2FA135-D157-41EF-879E-744B48E32C3E

Q37345354-0EF502F8-7F1E-4811-9CEF-4021AF2D6CAF

Q37345354-165D2F47-4CEE-44A6-9370-B0FA0E4387DD

Q37345354-18B85626-0AE8-431F-8B6B-3FED2C8EA852

Q37345354-1B7D9684-332C-4541-BA72-298299C37636

Q37345354-22455AFC-90B7-417B-B8E3-69C4F9885E82

Q37345354-2493E44A-77E5-404A-98EF-11C0828237B6

Q37345354-26F244AB-EEB3-4731-BB4D-4BD4A0EC4355

Q37345354-3496C867-6537-4915-BD55-60C934B40B8C

P2888

Q37345354-08CE1703-10A4-4561-B316-5F26B6DCB186

P304

Q37345354-E10DB22A-B2D5-4D1A-B2CC-C587F7BB1C79

P31

Q37345354-5396AEC2-3CB9-4B22-AD3F-A3296F9DDB42

P356

Q37345354-5AE3BC9B-80F6-46A9-9622-BE6DF0F97AB7

P407

Q37345354-61C267C6-D999-4AF4-9908-BCD1BD14FCEE

P433

Q37345354-E032AF19-6272-4B01-9054-49B2769087E9

P478

Q37345354-45ECF90B-0497-4A02-AB9A-4BEF13E3ECE2

P577

Q37345354-C2F911B7-C56F-4621-BA57-4014371AB273

P5875

Q37345354-7BA4BEA6-15F9-4F75-82B1-02EADBDBC857

P698

Q37345354-CF86A79E-5D7A-4710-BA38-6CDEE8901966

P932

Q37345354-2BADEDF7-343D-43B4-B695-30F4AABE14F8

P356

P1433

British Journal of Cancer

P1476

Securin promotes the identification of favourable outcome in invasive breast cancer.

@en

P2093

A Nieminen

http://www.w3.org/2001/XMLSchema#string

H Karra

http://www.w3.org/2001/XMLSchema#string

J Anttinen

http://www.w3.org/2001/XMLSchema#string

K Talvinen

http://www.w3.org/2001/XMLSchema#string

M Nykänen

http://www.w3.org/2001/XMLSchema#string

P Kronqvist

http://www.w3.org/2001/XMLSchema#string

S Hurme

http://www.w3.org/2001/XMLSchema#string

T Kuopio

http://www.w3.org/2001/XMLSchema#string

P2860

hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG

Regulation of human separase by securin binding and autocleavage

p100: a novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2, and M

The emerging role of pituitary tumor transforming gene in tumorigenesis

A gene-expression signature as a predictor of survival in breast cancer

An ESP1/PDS1 complex regulates loss of sister chromatid cohesion at the metaphase to anaphase transition in yeast

How do so few control so many?

Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

A molecular signature of metastasis in primary solid tumors

P2888

P304

1005-1010

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6605237

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26751308

http://www.w3.org/2001/XMLSchema#string

P698

19690544

http://www.w3.org/2001/XMLSchema#string

P932

2743366

http://www.w3.org/2001/XMLSchema#string